NL-OMON27592Not yet recruitingNot Applicable
Target Activated Clotting time for anticoagulation during cardiopulmonary bypass
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Enrollment
- 1,536
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Patients scheduled for elective CABG or cardiac valve surgery, or a combination of CABG with valve surgery, or (cross-clamped) aortic root or ascendens procedures with cardiopulmonary bypass.
- •Adult surgery
- •Informed consent
Exclusion Criteria
- •Re-operations
- •Aorta surgery (requiring SCP and/or circulatory arrest)
- •Emergency operation
- •Minimized extracorporeal circuits (MECC)
- •Deep hypothermia (<32oC)
- •Patients with congenital coagulation factor abnormalities (e.g. von Willebrand disease, hemophilia)
- •Patients with acquired coagulation factor abnormalities (e.g. acquired haemophilia, acquired von Willebrand disease, haematological malignities, thrombocytopenia <75*109/L)
- •Patients with anemia (hemoglobin value < 6.5 mmol/l)
Investigators
Similar Trials
Recruiting
Not Applicable
Target Activated Clotting Time for anticoagulation during cardiopulmonary bypassNL-OMON52711Perfusie1,010
Not yet recruiting
Not Applicable
Measuring the Activated Clotting Time in patients receiving unfractionated heparin prior to coronary angiography and intervention. A single-centre validation study comparing different blood sampling sitesNL-OMON44549oordwest Ziekenhuisgroep100
Withdrawn
Not Applicable
Measuring the Activated Clotting Time in patients receiving unfractionated heparin prior to coronary angiography and intervention. A single-centre validation study comparing different blood sampling sitesNL-OMON43038Medisch Centrum Alkmaar100
Not yet recruiting
Phase 3
Deciding the duration of blood thinners following acute venous thromboembolism (VTE) by assessing residual venous thrombosis by ultrasound scaCTRI/2023/06/053767Indian Council of Medical Research
Recruiting
Not Applicable
Optimal anticoagulation and antithrombotic treatment after PCI in AF patientsDiseases of the circulatory systemKCT0004860Yonsei University Health System, Severance Hospital960